Medical Equipment

Circulating Tumor Cells Market Forecast Through 2030 With Insights On Market Patterns And Developments

April 10, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Circulating Tumor Cells Market Expected To Scale Between 2026 And 2030?

The circulating tumor cells market has seen substantial growth over recent years. It is anticipated to expand from $13.27 billion in 2025 to $14.99 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 13.0%. This historical expansion can be attributed to several factors including rising cancer incidence rates, the broadening of oncology research programs, an increasing reliance on blood-based diagnostics, the greater adoption of minimally invasive testing methods, and the availability of advanced laboratory technologies.

The circulating tumor cells market size is anticipated to experience substantial growth in the coming years. It is projected to expand to $23.88 billion by 2030, achieving a compound annual growth rate (CAGR) of 12.3%. This expansion during the forecast period can be attributed to several factors, including the increasing uptake of personalized oncology diagnostics, greater investments in cancer biomarker research, the proliferation of automated cell capture technologies, a rising demand for tools to detect cancer at early stages, and the increasing incorporation of AI in oncology diagnostics. Significant trends for this period encompass the growing utilization of liquid biopsy techniques, an increase in the adoption of microfluidic CTC isolation devices, the expanding integration of automated CTC analysis systems, a broader application of oncology research, and a heightened emphasis on the early detection of cancer.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8950&type=smp

What Significant Factors Are Influencing The Circulating Tumor Cells Market Expansion?

The increasing occurrence of cancer is projected to drive the expansion of the circulating tumor cells market in the future. Cancer is defined as an illness where certain body cells proliferate without control and disseminate to various regions. Circulating tumor cells play a role in the early identification and diagnosis of cancer, consequently, the rising prevalence of cancer fuels the expansion of the circulating tumor cells market. To illustrate, data from February 2024 by the World Health Organization, an international organization based in Switzerland focused on global health policy and public health initiatives, forecasts more than 35 million new cancer cases by 2050, representing a 77% rise from the approximately 20 million cases estimated in 2022. Thus, the rising rate of cancer incidence is a key factor propelling the development of the circulating tumor cells market.

How Is The Circulating Tumor Cells Market Segmented Across Different Segment Categories?

The circulating tumor cells market covered in this report is segmented –

1) By Product: Kits And Reagents, Blood Collection Tubes, Devices Or Systems

2) By Technology: CTC Enrichment, CTC Detection, CTC Analysis

3) By Application: Clinical Or Liquid Biopsy, Research

Subsegments:

1) By Kits And Reagents: Cell Enrichment Kits, Detection Kits, Nucleic Acid Isolation Kits

2) By Blood Collection Tubes: Standard Blood Collection Tubes, Specialized Blood Collection Tubes

3) By Devices Or Systems: Microfluidic Devices, Automated Cell Capture Systems, Imaging Systems

What Trends Are Affecting The Direction Of The Circulating Tumor Cells Market?

Key companies in the circulating tumor cells (CTC) market are concentrating on developing innovative solutions, such as biomarker-specific CTC assays, to fulfill the increasing need for precise, non-invasive cancer diagnostics and advanced personalized therapy monitoring. These biomarker-specific CTC assays enable the identification and characterization of circulating tumor cells based on specific protein expression, providing more detailed phenotypic information than traditional CTC enumeration methods, which primarily offer total cell counts without distinguishing biomarkers. For instance, in July 2023, Menarini Silicon Biosystems S.p.A., an Italy-based diagnostics company, introduced the CELLSEARCH CTC test with the DLL3 biomarker, now accessible as a Research Use Only (RUO) service in North America and Europe. The assay employs the FDA-cleared CELLSEARCH platform to detect circulating tumor cells expressing DLL3, a protein overexpressed in aggressive small-cell lung cancer (SCLC) and neuroendocrine tumors. By focusing on DLL3, the test facilitates phenotypic characterization of CTCs associated with poor prognosis, thereby supporting biopharma research in developing targeted therapies. This innovation offers researchers a non-invasive tool to investigate tumor heterogeneity, monitor disease progression, and evaluate response to targeted treatments.

Which Organizations Play A Role In The Circulating Tumor Cells Market Landscape?

Major companies operating in the circulating tumor cells market are BIOCEPT Inc., Creativ MicroTech Inc., Fluxion Biosciences Inc., Ikonisys Inc., ScreenCell SAS, Aviva Biosciences Corporation, LungLife AI Inc., Menarini Silicon Biosystems S.p.A., Canopus Bioscience Ltd., IVDiagnostics Inc., BioFluidica Inc., Biolidics Limited, Rarecells Diagnostics SAS, Cynvenio Biosystems Inc., ApoCell Inc., Clearbridge BioMedics Pte. Ltd., Celsee Inc., RareCyte Inc., On-chip Biotechnologies Co. Ltd., Bio-Techne Corporation, Qiagen N.V., STEMCELL Technologies Inc., Sysmex Corporation, Miltenyi Biotec GmbH, Thermo Fisher Scientific Inc., Greiner Bio-One International GmbH, Agilent Technologies Inc.

Get The Full Circulating Tumor Cells Market Report:

https://www.thebusinessresearchcompany.com/report/circulating-tumor-cells-global-market-report

Which Region Holds The Highest Market Share In The Circulating Tumor Cells Market?

North America was the largest region in the circulating tumor cells market in 2025. Asia-Pacific is expected to be the fastest-growing region in the circulating tumor cells market during the forecast period. The regions covered in the circulating tumor cells market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Circulating Tumor Cells Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=8950&type=smp

Browse Through More Reports Similar to the Global Circulating Tumor Cells Market 2026, By The Business Research Company

Chronic Obstructive Pulmonary Disease Copd Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/chronic-obstructive-pulmonary-disease-copd-treatment-global-market-report

Anti Asthmatics And Copd Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/anti-asthmatics-and-copd-drugs-market

Anti Asthmatics And Copd Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/anti-asthmatics-and-copd-drugs-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795